Literature DB >> 28121354

Breast cancer metastasis suppressor 1 (BRMS1) suppresses prostate cancer progression by inducing apoptosis and regulating invasion.

H-M Zhang1, Q-D Qiao, H-F Xie, J-X Wei.   

Abstract

OBJECTIVE: Breast cancer metastasis suppressor 1 (BRMS1) was originally identified as a metastasis suppressor gene in human breast cancer.
MATERIALS AND METHODS: A recent study has established an association between BRMS1 with the clinical stage and different pathology grades of prostate cancer. However, whether BRMS1 plays a role in prostate cancer has not been elucidated.
RESULTS: In this study, we found that overexpression of BRMS1 in PC-3 cells induced apoptosis and inhibited invasion; moreover, we found that overexpression BRMS1 was associated with the suppressed expression of EMMPRIN.
CONCLUSIONS: Taken together, our results show that BRMS1 may suppress progression and metastasis of prostate cancer through modulating EMMPRIN expression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28121354

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

Review 1.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  MiR-147 inhibits cyclic mechanical stretch-induced apoptosis in L6 myoblasts via ameliorating endoplasmic reticulum stress by targeting BRMS1.

Authors:  Yanxiao Du; Feng Yang; Di Lv; Qiang Zhang; Xiao Yuan
Journal:  Cell Stress Chaperones       Date:  2019-10-18       Impact factor: 3.667

3.  Perturbation of BRMS1 interactome reveals pathways that impact metastasis.

Authors:  Rosalyn C Zimmermann; Mihaela E Sardiu; Christa A Manton; Md Sayem Miah; Charles A S Banks; Mark K Adams; Devin C Koestler; Douglas R Hurst; Mick D Edmonds; Michael P Washburn; Danny R Welch
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.752

4.  N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.

Authors:  Chenliang Zhou; Zhichang Zhang; Xiaoshi Zhu; Guowei Qian; Yan Zhou; Yong Sun; Wenxi Yu; Jiahui Wang; Haiyang Lu; Feng Lin; Zan Shen; Shuier Zheng
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.